N-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]sulfonyl-2-[2-methyl-5-(trifluoromethyl)anilino]-1,3-oxazole-4-carboxamide
C18H21F3N4O5S — CID 156549717
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]sulfonyl-2-[2-methyl-5-(trifluoromethyl)anilino]-1,3-oxazole-4-carboxamide
N-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]sulfonyl-2-[2-methyl-5-(trifluoromethyl)anilino]-1,3-oxazole-4-carboxamide (PubChem CID 156549717) has the molecular formula C18H21F3N4O5S and a molecular weight of 462.45 g/mol. Its IUPAC name is N-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]sulfonyl-2-[2-methyl-5-(trifluoromethyl)anilino]-1,3-oxazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]sulfonyl-2-[2-methyl-5-(trifluoromethyl)anilino]-1,3-oxazole-4-carboxamide |
|---|---|
| PubChem CID | 156549717 |
| Molecular Formula | C18H21F3N4O5S |
| Molecular Weight | 462.45 g/mol |
| Exact Mass | 462.12 |
| IUPAC Name | N-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]sulfonyl-2-[2-methyl-5-(trifluoromethyl)anilino]-1,3-oxazole-4-carboxamide |
| SMILES | COC[C@H]1CCCN1S(=O)(=O)NC(=O)c1coc(Nc2cc(C(F)(F)F)ccc2C)n1 |
| InChI | InChI=1S/C18H21F3N4O5S/c1-11-5-6-12(18(19,20)21)8-14(11)22-17-23-15(10-30-17)16(26)24-31(27,28)25-7-3-4-13(25)9-29-2/h5-6,8,10,13H,3-4,7,9H2,1-2H3,(H,22,23)(H,24,26)/t13-/m1/s1 |
| InChIKey | ZEYLULDTZOUAMX-CYBMUJFWSA-N |
| XLogP | 2.83 |
| TPSA | 113.77 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 462.45 |
| LogP ≤ 5 | 2.83 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156549717 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.